Abstract | AIM: METHODS: AOM (10 mg/kg, i.p.) on day 0 induced colorectal carcinogenesis. On day 3, mice were provided with water containing 1.5% (w/v) DSS ad libitum for 3 day, and this 3-day drinking protocol was repeated twice. Piceatannol (5 and 12.5 mg/kg, twice daily) was orally administered to mice for 7-, 7-, 7-, and 6-day and then discontinued for 14-, 15-, and 16-day. Cytokines, chemokine, and PD-1 colon levels were measured by the respective ELISA kits. RESULTS: In mice administered piceatannol (12.5 mg/kg), the tumor number, tumor area, and Ki-67-positive cell numbers decreased by 30.1%, 57.2%, and 89.1%, respectively, colon MCP-1 and PD-1 levels showed reductions of 43.8% and 70.9%, respectively, and COX-2-positive cell numbers declined by 60.2%. CONCLUSIONS: The inhibitory effects of piceatannol on AOM/DSS-induced colon tumor growth appear to be associated with reductions in colon MCP-1 and PD-1 levels through the downregulated expression of COX-2 in the tumor microenvironment.
|
Authors | Yoshiyuki Kimura |
Journal | Nutrition and cancer
(Nutr Cancer)
Vol. 74
Issue 6
Pg. 2184-2195
( 2022)
ISSN: 1532-7914 [Electronic] United States |
PMID | 34622729
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytokines
- Programmed Cell Death 1 Receptor
- Stilbenes
- Vascular Endothelial Growth Factor A
- 3,3',4,5'-tetrahydroxystilbene
- Dextran Sulfate
- Cyclooxygenase 2
- Azoxymethane
|
Topics |
- Administration, Oral
- Animals
- Azoxymethane
(toxicity)
- Colitis
(chemically induced)
- Colon
(metabolism)
- Colonic Neoplasms
(chemically induced, drug therapy, metabolism)
- Cyclooxygenase 2
(metabolism)
- Cytokines
(metabolism)
- Dextran Sulfate
(toxicity)
- Disease Models, Animal
- Mice
- Mice, Inbred C57BL
- Programmed Cell Death 1 Receptor
(metabolism)
- Stilbenes
- Tumor Microenvironment
- Vascular Endothelial Growth Factor A
(metabolism)
|